Business and Finance

Company markets unique approach to managing pharma supply chains

The big pharma will help fill and finish up to 60 million doses of Novavax' coronavirus candidate

Deal allows for more transport options, temperature control

Makes up to 400 million doses of J&J's Covid vaccine available to the African Union through 2022

Biomedical freezer maker to combine with supplier of cell and gene therapy tools

Cell culture facility expected to be largest in North America, according to the manufacturer

The commission is launching a broad review of drug-company mergers to explore how such deals can potentially harm industry competition

Production will occur at IDT’s Germany facilities for a three-month span

Agreement focused on enhancing insights into the location and condition of temperature-sensitive drugs and vaccines, including ones for Covid-19

Deal bolsters ANI’s generics and CDMO portfolio

More than $600 million in backing opens the door for additional manufacturing capacity, further Covid-19 preparations

Company’s rebranded platform, Ocellos, will manage complex handoffs in cell and gene therapy (CGT) treatments and trials

Agreements to focus on driving adoption of AI and natural language processing for medical affairs programs

The 130,000-square-foot site will be the CDMO's third location

Ten million doses expected by end of Q3

Partnership’s priority is to evaluate mental health medication

Marks the latest big pharma partnership for CureVac around its Covid vaccine candidate, CVnCoV

Drone technology delivers doses to difficult-to-reach locations

In extension of J&J agreement, deal provides manufacturing facilities for Covid-19 vaccine production

Rivals will team up in order to accelerate supply

UK-based OXGENE designs and develops scalable gene therapy technologies

Purchase expands CRO's plans for cell and gene therapy program

Alliance with Jointown comes in time for Covid-19 vaccine storage and distribution efforts

Joins UK consortium to help efficiently manufacture oral solid dosage medication

Deals provide Andlauer Healthcare Group full Skeleton Canada ownership and 49 percent stake in US branch